Under the proposed rule, HHS would determine whether regulations are subject to review under the Regulatory Flexibility Act, which requires regular review of significant regulations. HHS regulations will expire if the department does not review and assess them in a timely manner if required.
“This proposal — the boldest and most significant regulatory reform effort ever undertaken by HHS — would sunset burdensome regulations unless their necessity is publicly demonstrated to the American people,” said HHS Chief of Staff Brian Harrison in a news release.
HHS will accept comments on the proposed rule until Dec. 4.
More articles on legal and regulatory issues:
ER physicians accuse UnitedHealth of illegally underpaying claims
California health system pays $31.5M to settle drug overbilling case
Medtronic will pay $9.2M settlement over alleged kickbacks to neurosurgeon
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
